Variant Synonymizer: Platform to identify mutations defined in different ways is available now!
Over 2,000 gene–disease validation summaries are now available—no login required!
X-linked Opitz G/BBB syndrome is an X-linked recessive developmental disorder characterized by midline defects including hypertelorism, hypospadias, cleft lip/palate, laryngotracheoesophageal clefts and anal atresia. The MID1 gene, encoding a RBCC/TRIM family microtubule-associated ubiquitin E3 ligase, was first implicated through chromosomal inversion and mutation analysis in a 1997 Nature Genetics report (PMID:9354791), establishing a direct genetic link to the disease.
Genetic analyses across multiple cohorts have identified MID1 mutations in over 148 probands (PMID:11030761; PMID:12833403; PMID:15558842) segregating in at least 5 X-linked families. The inheritance pattern is X-linked recessive, with male hemizygotes fully manifesting the phenotype and carrier females showing milder hypertelorism (PMID:15558842).
The MID1 variant spectrum includes at least 30 truncating (nonsense, frameshift, splice) and over 15 missense alleles distributed throughout the RING-B-box and coiled-coil domains. In-frame insertions and deletions are also reported predominantly in the C-terminal regions, underscoring loss-of-function as the predominant mechanism (PMID:11030761; PMID:12833403; PMID:15558842).
A recently described missense variant, c.608G>A (p.Arg203Gln), was identified in two affected male siblings with total anomalous pulmonary venous connection and midline dysmorphias, expanding the cardiac phenotype of Opitz GBBB syndrome (PMID:37498300).
Functional studies demonstrate that MID1 associates with microtubules and that patient-derived missense and truncating variants abolish this interaction, forming cytoplasmic aggregates instead of normal microtubular colocalization (PMID:10077590; PMID:11371618). Furthermore, MID1 mutations impair ubiquitination of the α4 regulatory subunit of PP2A, perturbing phosphatase regulation critical for midline development.
Integration of extensive genetic segregation, variant spectrum, and concordant experimental data supports a definitive gene–disease relationship. MID1 mutational analysis is clinically actionable for diagnostic confirmation, familial testing, and potential targeted interventions in X-linked Opitz G/BBB syndrome.
Gene–Disease AssociationDefinitiveOver 148 probands across >15 families with segregation and concordant functional data Genetic EvidenceStrong148 probands ([PMID:11030761]; [PMID:12833403]; [PMID:15558842]) and segregation in 5 families Functional EvidenceModerateMutations disrupt microtubule association and ubiquitination in cellular assays ([PMID:10077590]; [PMID:11371618]) |